Senior Prescription Drug Assistance Program – Sunset Extension
Impact
Under SB219, the Senior Prescription Drug Assistance Program will continue to offer subsidies to eligible individuals, which can help cover deductibles, coinsurance payments, and premiums associated with Medicare Part D. These actions are expected to strengthen the support system for seniors in Maryland who require medication. It is set to positively affect the healthcare landscape by easing financial pressures on seniors, particularly those with lower incomes, allowing them access to essential medication without significant out-of-pocket costs.
Summary
Senate Bill 219, known as the Senior Prescription Drug Assistance Program - Sunset Extension, aims to extend the termination date of the Senior Prescription Drug Assistance Program in Maryland. This program is designed to provide financial assistance to eligible Medicare beneficiaries, aiding them in covering the costs of prescription drugs. The bill specifically focuses on ensuring continuity of benefits for individuals enrolled in the program by preventing any interruptions as the transition between related plans occurs.
Sentiment
The general sentiment towards SB219 appears to be supportive, particularly among healthcare advocates and senior citizen organizations. The bill is seen as a necessary measure to protect vulnerable populations from rising prescription drug costs. However, there may be some concerns regarding the adequacy of funding for the program, especially if there is an increase in the number of eligible enrollees due to extended benefits. Legislative discussions revealed optimism about the program's popularity, indicating a collective interest in enhancing healthcare accessibility for seniors.
Contention
While the bill has garnered support, there are nuanced discussions regarding funding limitations that may impact the program's effectiveness. Critics might point out that while extending the program is beneficial, the future sustainability of subsidies will depend on available state resources. The ongoing challenge will be to secure sufficient funds to meet the demand from eligible participants without compromising the quality or extent of the program offered, ensuring that the initiative is not merely a temporary fix but a sustained long-term strategy for assisting Maryland's seniors.
Maryland Medical Assistance Program and Health Insurance - Coverage and Utilization Review - Drugs Reviewed by the Prescription Drug Affordability Board
Maryland Medical Assistance Program and Health Insurance - Coverage and Utilization Review - Drugs Reviewed by the Prescription Drug Affordability Board
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.